Filing Details

Accession Number:
0001209191-15-084885
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-14 11:52:17
Reporting Period:
2015-12-10
Filing Date:
2015-12-14
Accepted Time:
2015-12-14 11:52:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI Pharmaceutical Preparations (2834) 943254365
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1491874 M. Geoffrey Parker C/O Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-10 15,379 $7.23 34,979 No 4 P Indirect Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
Common Stock Acquisiton 2015-12-11 4,621 $7.30 39,600 No 4 P Indirect Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
No 4 P Indirect Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 39,600 Indirect Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
Common Stock 5,000 Indirect By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA
Common Stock 13,514 Direct
Footnotes
  1. Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $7.01 to $7.53 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
  2. Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $7.16 to $7.43 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.